Related Experiment Video
Updated: Feb 28, 2026

Handwriting Analysis Indicates Spontaneous Dyskinesias in Neuroleptic Naïve Adolescents at High Risk for Psychosis
Published on: November 21, 2013
[Delayed diagnosis of Huntington's disease in a psychiatric setting]
Insights
Huntington's disease, a neurodegenerative disorder, often presents with psychiatric symptoms that can delay diagnosis. This study examines three cases where initial neuropsychiatric signs in Huntington's disease led to misdiagnosis and delayed treatment.
Area of Science:
- Neuroscience
- Psychiatry
- Genetics
Background:
- Huntington's disease (HD) is an inherited neurodegenerative disorder.
- It is characterized by a combination of motor, cognitive, and psychiatric symptoms.
- Early symptoms can be subtle and varied, complicating diagnosis.
Observation:
- The triad of symptoms includes motor disturbances, cognitive decline, and neuropsychiatric issues.
- Neuropsychiatric symptoms, such as depression or anxiety, may manifest before motor symptoms.
- Misinterpretation of initial psychiatric symptoms can lead to diagnostic delays.
Findings:
- Three case studies illustrate delayed diagnosis of Huntington's disease in psychiatric settings.
- Patients initially presented with neuropsychiatric symptoms that were mistaken for primary psychiatric disorders.
- The correct diagnosis of Huntington's disease was established after a significant delay.
Implications:
- Highlighting the importance of considering Huntington's disease in patients with unexplained neuropsychiatric symptoms.
- Emphasizes the need for comprehensive diagnostic evaluation in psychiatric patients.
- Suggests improved screening protocols for Huntington's disease in psychiatric care settings.
Abstract:
Huntington's disease (hd) is characterised by a triad of neuropsychiatric symptoms, motor disturbances and cognitive decline. If initial symptoms are of neuropsychiatric nature they maybe misinterpreted, which can lead to delayed diagnosis. Three examples of delayed hd diagnosis in a psychiatric setting are discussed.
Related Concept Videos
Psychosis: Goals of Pharmacotherapy
Parkinson's Disease: Treatment
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Psychosis and Antipsychotic Drugs: Overview
Psychosis: Pathophysiology of Schizophrenia and Other Psychotic Disorders
Researchers have identified genetic factors that increase susceptibility to schizophrenia, underscoring the intricate interplay between genetics and environment in disease development. At the core of schizophrenia's pathophysiology is excessive dopaminergic neurotransmission within...
Drug Therapy
Antianxiety Medications
Schizophrenia

